Apeiron and Rentschler Announces Partnership Agreement|
Friday, August 02, 2013
Rentschler produces Apeiron's monoclonal antibody APN311 for late stage clinical development and market.
Thermo Fisher Scientific Showcases New Small Benchtop Centrifuge at AACC
Thursday, August 01, 2013
Provides scientists with outstanding capacity in a compact design.
Intelsius Introduces Reusable Courier Transit Case
Monday, July 29, 2013
BioCarrier™ - Designed for local courier routes and multiple site sample collections.
BASF, Cargill and Novozymes Achieve Milestone in Bio-Based Acrylic Acid Process
Thursday, July 11, 2013
Success in producing 3-hydroxypropionic acid for bio-based acrylic acid.
Ask the Expert: Strategies to Maximize Return on Idle Equipment
Monday, June 24, 2013
Roger Gallo answers some frequently asked questions about how to achieve a good return on equipment.
Reaction Biology Top-Ranked in Kinase Profiling Survey
Wednesday, June 19, 2013
RBC also ranked highly on technical support and data quality.
Cobra Biologics and Novolytics Unveil Successful Development of Bacteriophages Against Bacterial Infection
Wednesday, June 12, 2013
Cobra to present its methodology, approach, and acquired expertise in phage manufacture at the Phages 2013.
Novel Saltwater Treatment Device
Monday, May 27, 2013
Cambridge Consultants develops innovative nebulizer to treat cystic fibrosis.
Novozymes Biopharma’s Recombinant Human Albumin Helps Dry Eye Therapy Move into Clinical Trials
Wednesday, May 22, 2013
A novel ophthalmic solution from R-Tech Ueno (Tokyo, Japan) made using Novozymes Biopharma’s recombinant human albumin has recently obtained FDA approval to undergo Phase I/II clinical trials in the United States.